The Irritable Bowel Syndrome -- a Clinical Review and Ethical Considerations
Creator
Kirsner, Joseph B.
Bibliographic Citation
ARCHIVES OF INTERNAL MEDICINE 141(5): 635-639, April 1981
Date
1981-04Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
FDA [Food and Drug Administration] recommends bringing controversial IBS [irritable bowel syndrome] drug back [Alosetron]
McCarthy, Michael (2002-04-27)